Pfizer to buy Wyeth for $68 billion
(Reuters)
<p><img src="http://d.yimg.com/us.yimg.com/p/nm/20090126/2009_01_26t121922_450x334_us_wyeth_pfizer.jpg?x=130&y=96&q=85&sig=QwPpjzOA0imjgUZfkCPJOg--" align="left" height="96" width="130" alt="Jeffrey Kindler (L), Chairman and CEO of Pfizer, and Bernard Poussot, Chairman and CEO of Wyeth, shake hands after a news conference announcing the merger of the two companies in New York, January 26, 2009. (Brendan McDermid/Reuters)" border="0" /> (http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20090126/bs_nm/us_wyeth_pfizer)Reuters - Pfizer Inc, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base.</p><br clear="all"/>
http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20090126/bs_nm/us_wyeth_pfizer